JP2016531563A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016531563A5 JP2016531563A5 JP2016525279A JP2016525279A JP2016531563A5 JP 2016531563 A5 JP2016531563 A5 JP 2016531563A5 JP 2016525279 A JP2016525279 A JP 2016525279A JP 2016525279 A JP2016525279 A JP 2016525279A JP 2016531563 A5 JP2016531563 A5 JP 2016531563A5
- Authority
- JP
- Japan
- Prior art keywords
- cancer
- liver
- hcc
- medicament
- use according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 206010028980 Neoplasm Diseases 0.000 claims 2
- 201000011510 cancer Diseases 0.000 claims 2
- 201000007270 liver cancer Diseases 0.000 claims 2
- 208000014018 liver neoplasm Diseases 0.000 claims 2
- 108091032973 (ribonucleotides)n+m Proteins 0.000 claims 1
- 206010006187 Breast cancer Diseases 0.000 claims 1
- 208000026310 Breast neoplasm Diseases 0.000 claims 1
- 206010009944 Colon cancer Diseases 0.000 claims 1
- 208000008839 Kidney Neoplasms Diseases 0.000 claims 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 claims 1
- 206010033128 Ovarian cancer Diseases 0.000 claims 1
- 206010061535 Ovarian neoplasm Diseases 0.000 claims 1
- 206010061902 Pancreatic neoplasm Diseases 0.000 claims 1
- 206010060862 Prostate cancer Diseases 0.000 claims 1
- 208000000236 Prostatic Neoplasms Diseases 0.000 claims 1
- 206010038389 Renal cancer Diseases 0.000 claims 1
- 108020004459 Small interfering RNA Proteins 0.000 claims 1
- 208000005718 Stomach Neoplasms Diseases 0.000 claims 1
- 208000029742 colonic neoplasm Diseases 0.000 claims 1
- 239000002552 dosage form Substances 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 206010017758 gastric cancer Diseases 0.000 claims 1
- 201000010982 kidney cancer Diseases 0.000 claims 1
- 201000005202 lung cancer Diseases 0.000 claims 1
- 208000020816 lung neoplasm Diseases 0.000 claims 1
- 208000015486 malignant pancreatic neoplasm Diseases 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 239000002105 nanoparticle Substances 0.000 claims 1
- 201000002528 pancreatic cancer Diseases 0.000 claims 1
- 208000008443 pancreatic carcinoma Diseases 0.000 claims 1
- 201000011549 stomach cancer Diseases 0.000 claims 1
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 6
- 235000019152 folic acid Nutrition 0.000 description 5
- 239000011724 folic acid Substances 0.000 description 4
- OVRNDRQMDRJTHS-CBQIKETKSA-N N-Acetyl-D-Galactosamine Chemical compound CC(=O)N[C@H]1[C@@H](O)O[C@H](CO)[C@H](O)[C@@H]1O OVRNDRQMDRJTHS-CBQIKETKSA-N 0.000 description 2
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 2
- MBLBDJOUHNCFQT-UHFFFAOYSA-N N-acetyl-D-galactosamine Natural products CC(=O)NC(C=O)C(O)C(O)C(O)CO MBLBDJOUHNCFQT-UHFFFAOYSA-N 0.000 description 2
- 229940014144 folate Drugs 0.000 description 2
- 229960000304 folic acid Drugs 0.000 description 2
- -1 glucose and mannose Chemical class 0.000 description 2
- 108091023037 Aptamer Proteins 0.000 description 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 150000002224 folic acids Chemical class 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 235000010299 hexamethylene tetramine Nutrition 0.000 description 1
- 239000003446 ligand Substances 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR10-2013-0080579 | 2013-07-09 | ||
| KR20130080579A KR20150006742A (ko) | 2013-07-09 | 2013-07-09 | 간암 연관 유전자 특이적 siRNA, 그러한 siRNA를 포함하는 이중나선 올리고 RNA 구조체 및 이를 포함하는 암 예방 또는 치료용 조성물 |
| PCT/KR2014/006145 WO2015005669A1 (en) | 2013-07-09 | 2014-07-09 | LIVER CANCER RELATED GENES-SPECIFIC siRNA, DOUBLE-STRANDED OLIGO RNA MOLECULES COMPRISING THE siRNA, AND COMPOSITION FOR PREVENTING OR TREATING CANCER COMPRISING THE SAME |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2016531563A JP2016531563A (ja) | 2016-10-13 |
| JP2016531563A5 true JP2016531563A5 (enExample) | 2016-12-01 |
Family
ID=52280271
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016525279A Withdrawn JP2016531563A (ja) | 2013-07-09 | 2014-07-09 | 肝臓癌関連遺伝子特異的ｓｉＲＮＡ、そのようなｓｉＲＮＡを含む二重らせんオリゴＲＮＡ構造体及びこれを含む癌予防または治療用組成物 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20160168573A1 (enExample) |
| EP (1) | EP3019611A4 (enExample) |
| JP (1) | JP2016531563A (enExample) |
| KR (1) | KR20150006742A (enExample) |
| CN (1) | CN105765069A (enExample) |
| SG (1) | SG11201600076WA (enExample) |
| WO (1) | WO2015005669A1 (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3689355A4 (en) * | 2017-07-28 | 2021-09-08 | Lemonex Inc. | PHARMACEUTICAL COMPOSITION FOR THE PREVENTION OR TREATMENT OF LIVER CANCER |
| CN110964816A (zh) * | 2019-11-20 | 2020-04-07 | 深圳市鲲鹏未来科技有限公司 | 包含血液稳定性纳米颗粒的溶液、其制备方法及miRNA标志物的检测方法 |
| CN111189808B (zh) * | 2019-12-25 | 2022-12-06 | 宁夏医科大学总医院 | 与肝脏损伤、肝细胞凋亡相关特异蛋白分子标志物筛选方法 |
| CN111596059A (zh) * | 2020-05-19 | 2020-08-28 | 上海长海医院 | Gankyrin蛋白作为新型分子标志物在前列腺癌预后评估中的应用 |
| KR102329524B1 (ko) * | 2021-08-06 | 2021-11-23 | 주식회사 네오나 | 변형된 rt-let7을 유효성분으로 포함하는 간암의 예방 또는 치료용 조성물 |
| WO2023013818A1 (ko) * | 2021-08-06 | 2023-02-09 | 주식회사 네오나 | 변형된 rt-let7을 유효성분으로 포함하는 간암의 예방 또는 치료용 조성물 |
| EP4594502A2 (en) * | 2022-09-28 | 2025-08-06 | Ohio State Innovation Foundation | Rna complexes and nanostructures for treatment of cancer metastasis |
| CN117281792A (zh) * | 2023-07-25 | 2023-12-26 | 浙江大学 | 一种用于增强肝癌免疫疗法治疗效果的纳米制剂 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1994022468A1 (en) * | 1993-04-02 | 1994-10-13 | Anticancer, Inc. | Method for delivering beneficial compositions to hair follicles |
| DK2284266T3 (da) * | 2002-11-14 | 2014-01-13 | Thermo Fisher Scient Biosciences Inc | sIRNA-MOLEKYLE MOD TP53 |
| WO2006006948A2 (en) * | 2002-11-14 | 2006-01-19 | Dharmacon, Inc. | METHODS AND COMPOSITIONS FOR SELECTING siRNA OF IMPROVED FUNCTIONALITY |
| CA2581190A1 (en) * | 2004-09-29 | 2006-04-13 | Alza Corporation | Microparticles and nanoparticles containing a lipopolymer |
| CA2675834A1 (en) * | 2007-01-16 | 2008-07-24 | Proteologics, Ltd. | Methods for enhancing the therapeutic efficacy of topoisomerase inhibitors |
| KR101224828B1 (ko) * | 2009-05-14 | 2013-01-22 | (주)바이오니아 | ｓｉＲＮＡ 접합체 및 그 제조방법 |
| KR101230913B1 (ko) * | 2009-11-06 | 2013-02-07 | 중앙대학교 산학협력단 | 나노입자-기반된 유전자 운반체 |
| RU2599449C1 (ru) * | 2011-12-15 | 2016-10-10 | Байонир Корпорейшн | Новые конъюгаты олигонуклеотидов и их применение |
-
2013
- 2013-07-09 KR KR20130080579A patent/KR20150006742A/ko not_active Withdrawn
-
2014
- 2014-07-09 WO PCT/KR2014/006145 patent/WO2015005669A1/en not_active Ceased
- 2014-07-09 JP JP2016525279A patent/JP2016531563A/ja not_active Withdrawn
- 2014-07-09 EP EP14822311.8A patent/EP3019611A4/en not_active Withdrawn
- 2014-07-09 SG SG11201600076WA patent/SG11201600076WA/en unknown
- 2014-07-09 CN CN201480048986.8A patent/CN105765069A/zh active Pending
- 2014-07-09 US US14/902,808 patent/US20160168573A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2016531563A5 (enExample) | ||
| Giuliano et al. | Mechanisms of resistance to anti-angiogenesis therapies | |
| Laurent et al. | Magnetic fluid hyperthermia: focus on superparamagnetic iron oxide nanoparticles | |
| CN109661394A (zh) | Fgfr4抑制剂、其制备方法与药学上的应用 | |
| JP2019526543A5 (enExample) | ||
| AR089529A1 (es) | Proteinas de union especificas duales dirigidas contra il-13 y/o il-17 | |
| JP2018513104A5 (enExample) | ||
| WO2014135282A8 (en) | Amatoxin derivatives | |
| NZ701575A (en) | Combination therapy involving antibodies against claudin 18.2 for treatment of cancer | |
| BR112014027952A2 (pt) | anticorpos capazes de se ligar ao fator xi de coagulação e/ou à sua forma ativada fator xia e suas utilizações. | |
| EA201890272A1 (ru) | Axl-специфические конъюгаты антитело-лекарственное средство для лечения рака | |
| JP2015516989A5 (enExample) | ||
| WO2014163714A3 (en) | Antibody drug conjugates | |
| MX2013010286A (es) | Conjugados de amatoxinas con enlaces mejorados. | |
| BR112012024710A8 (pt) | moléculas que se ligam ao antígeno, seus processos de produção, bem como composição farmacêutica que as compreendem | |
| WO2014191359A9 (en) | Aptamers and use of the aptamers in the diagnosis and treatment of cancer | |
| WO2015058861A8 (en) | Bispecific constructs and their use in the treatment of various diseases | |
| MX2016000019A (es) | (arnip) gen especifico relacionado con las enfermedades respiratorias, (arnip) que contiene la estructura arn oligo helicoidal, composicion que contiene la misma para prevencion o tratamiento de las enfermedades respiratorias. | |
| MX2015013166A (es) | Proteinas de union especificas duales dirigidas contra il-1 beta y/o il-17. | |
| HK1252852A1 (zh) | 阻止HIF2α基因表达的组合物及方法 | |
| CA2939931C (en) | METHODS AND COMPOSITIONS FOR TREATING DISEASES ASSOCIATED WITH SIGLEC8 | |
| JP2016526021A5 (enExample) | ||
| JP2017532332A5 (enExample) | ||
| IN2012DE00138A (enExample) | ||
| JP2015500286A5 (enExample) |